New Agents
92-C-0137:
A Trial of Carboxypeptidase-G2 (CPDG2) for the Management of Intrathecal
Methotrexate Overdoses
Principal Investigator: Dr. Brigitte Widemann
01-C-0091:
A Phase I Trial and Pharmacokinetic Study of Tariquidar, a P-Glycoprotein
Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel
in Pediatric Patients with Refractory Solid Tumors Including Brain
Tumors
Principal Investigator: Dr. Frank Balis
02-C-0031:
A Phase I trial and pharmacokinetic study of BMS-247550 (NSC 710428),
an epothilone B analog, in pediatric patients with refractory solid
tumors
Principal Investigator: Dr. Brigitte Widemann
02-C-0141:
A Phase I Trial and Pharmacokinetic Study of ABT-751, an Orally
Bioavailable Tubulin Binding Agent, in Pediatric Patients with Refractory
Solid Tumors
Principal Investigator: Dr. Frank Balis
Last Updated:
:July 25, 2006
NCI
Home Page|| NIH Home Page
© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research,
National Cancer Institute
|